Literature DB >> 3164028

Saliva inhibits HIV-1 infectivity.

P C Fox1, A Wolff, C K Yeh, J C Atkinson, B J Baum.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3164028     DOI： 10.14219/jada.archive.1988.0002

Source DB:  PubMed          Journal:  J Am Dent Assoc        ISSN： 0002-8177            Impact factor:   3.634


× No keyword cloud information.
  22 in total

1.  Disease transmission and cardiopulmonary resuscitation. Emergency Cardiac Care Committee, Heart and Stroke Foundation of Canada.

Authors: 
Journal:  CMAJ       Date:  1990-11-15       Impact factor: 8.262

Review 2.  Antiviral activities in human saliva.

Authors:  D Malamud; W R Abrams; C A Barber; D Weissman; M Rehtanz; E Golub
Journal:  Adv Dent Res       Date:  2011-04

Review 3.  Positive and negative aspects of the human immunodeficiency virus protease: development of inhibitors versus its role in AIDS pathogenesis.

Authors:  K Ikuta; S Suzuki; H Horikoshi; T Mukai; R B Luftig
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

4.  Enhanced secretory leukocyte protease inhibitor in human immunodeficiency virus type 1-infected patients.

Authors:  A A Baqui; T F Meiller; W A Falkler
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

5.  Localization of the genes for histatins to human chromosome 4q13 and tissue distribution of the mRNAs.

Authors:  J C vanderSpek; H E Wyandt; J C Skare; A Milunsky; F G Oppenheim; R F Troxler
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

6.  HIV seroconversion in two homosexual men after receptive oral intercourse with ejaculation: implications for counseling concerning safe sexual practices.

Authors:  A R Lifson; P M O'Malley; N A Hessol; S P Buchbinder; L Cannon; G W Rutherford
Journal:  Am J Public Health       Date:  1990-12       Impact factor: 9.308

7.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

8.  Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.

Authors:  S M Wahl; P Worley; W Jin; T B McNeely; S Eisenberg; C Fasching; J M Orenstein; E N Janoff
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

9.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 10.  Oral diseases in HIV-1 infection.

Authors:  C E Barr
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.